TOP > News Release > list in 2007
- 2007.11.30
- Share Transfer of NIPPON NYUKAZAI and SINO-JAPAN CHEMICAL
(subsidiaries of DAIICHI SANKYO)
- 2007.11.04
- In Landmark Phase III Head-to-Head Study, Prasugrel Statistically
Superior to Clopidogrel in Reducing Risk of Heart Attack
- 2007.11.04
- Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
- 2007.10.01
- DAIICHI SANKYO EUROPE is applying for approval of its new
combination product of Olmesartan and Amlodipin
- 2007.09.28
- Application Filed for Additional Indication for Selective Antithrombin Agents Novastan(R) HI Injection 10mg/2mL and Slonnon(R) HI Injection 10mg/2mL for Heparin-Induced Thrombocytopenia
- 2007.08.28
- Additional Pediatric Indication for Fentanyl Injection Approved
Japan's First Ever Approval of Physician-led Clinical Trial
- 2007.08.22
- Daiichi Sankyo and Forest Laboratories Sign Letter of Intent for Co-Promotion of AZOR(TM)
- 2007.07.12
- Amgen Grants Daiichi Sankyo Exclusive Rights to Develop and
Commercialize Denosumab in Japan
- 2007.05.22
- Amlodipine and Olmesartan Study Results Released;
Late Breaker Presented at American Society of Hypertension
Twenty-Second Annual Scientific Meeting (ASH 2007)
First Release of Data for New Combination
- 2007.03.01
- Daiichi Pharmaceutical Concludes Joint Promotion of Plavix (R) with Sanofi-aventis
